easl studio - s6e13 promo - resmetirom: first approved drug for mash, for whom and for how long?
Published 5 months ago • 631 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:03
easl studio - s5e13 promo - basics in decision-making for liver cancer treatment
-
1:05
easl studio s6e12 promo - do we care enough about the importance of dili/dhili ?
-
0:49
easl studio - s6e03 promo - how to stop recurrent bleeding due to small-intestinal angiodysplasia?
-
32:44
easl studio s3e14 - the future of hepatology
-
0:56
easl studio s3e13 teaser
-
1:22
easl studio s6e10 promo - yi choice: citizen science: societal engagement in hepatology
-
8:29
easl studio policy dialogues episode 3 - liver cancer: the risk of ignorance
-
1:29:17
biochemistry of the senses 2024
-
37:54
easl studio - special edition - live from the liver cancer summit 2022
-
32:12
easl studio s6 e14 - endohepatology: the endoscopic liver gold rush
-
34:57
easl studio - s3e16 - liver cancer in 2022: wrap-up & outlook
-
1:11
easl studio s6e8 promo - is there a role for measuring blood ammonia in patients with cirrhosis?
-
1:01
easl studio s5e04 promo video - pbc: the itch we need to scratch
-
1:21
easl studio s6e15 promo - what‘s hot in viral hepatitis in 2024?
-
1:38
s4e16 promo - highlights from the easl liver cancer summit 2023
-
1:28
easl studio s5e3 promo video - zoonotic hepatitis e – what’s hot in 2023?
-
0:51
easl studio s5e2 promo: a critical view on steatotic liver disease and care pathways
-
1:05
easl studio - promo video - special edition – highlights from the easl sld summit 2023
-
1:14
easl studio s6e7 promo - the hepahealth ii study
-
1:44
s4e3 promo - a 360 approach to beat alcohol-related liver disease
-
2:00
s4e6 promo - regenerating the liver graft with a machine